TNFRSF8 and myeloid neoplasm: Immunohistochemically, positive staining for tryptase and CD117 (c-kit) confirm mast cell lineage, while CD25, CD30 and CD2 distinguish SM from reactive mastocytosis or other myeloid neoplasms [19].